Sinkeviciute, Dovile
Skovlund Groen, Solveig
Sun, Shu
Manon-Jensen, Tina
Aspberg, Anders
Önnerfjord, Patrik
Bay-Jensen, Anne-Christine
Kristensen, Salome
Holm Nielsen, Signe
Funding for this research was provided by:
Stiftelsen för Strategisk Forskning (ID15-0035)
Gigtforeningen
Psoriasisforeningen
Innovationsfonden (8054-00006B)
Article History
Received: 14 April 2020
Accepted: 25 June 2020
First Online: 11 August 2020
Competing interests
: DS and SSG are industrial PhD students, ACBJ, SHN, SS and TMJ are full-time employees at Nordic Bioscience A/S. ACBJ holds stocks in Nordic Bioscience. Nordic Bioscience is a privately-owned, small–medium size enterprise (SME) partly focused on the development of biomarkers. AA, SK and PÖ have no competing interests. The study was supported by an industrial PhD scholarship grant (ID15-0035) from Swedish Strategic Research Foundation (SSF)—recipients PÖ and ACBJ. None of the authors received fees, bonuses or other benefits for the work described in the manuscript.